Researchers at the University of Florida and Trinity College Dublin have identified the SLC35F2 gene as the long-sought transporter responsible for the cellular absorption of queuosine, a micronutrient vital for brain health, memory, and cancer defense. This breakthrough, published in the Proceedings of the National Academy of Sciences, resolves a 30-year mystery regarding how queuosine enters human cells, which has significant implications for understanding its role in health and disease.

The significance of this discovery lies in queuosine’s multifaceted role in gene expression and protein synthesis. By modifying transfer RNA, queuosine enhances the accuracy with which cells interpret genetic information, thereby influencing critical biological processes. The identification of SLC35F2 not only elucidates the mechanism of queuosine absorption but also opens avenues for therapeutic development that leverage this nutrient’s protective effects against neurodegeneration and cancer. The collaborative effort across multiple institutions underscores the importance of interdisciplinary research in addressing complex biological questions.

This finding shifts the paradigm in nutrition and healthspan research by highlighting the critical interplay between diet, gut microbiota, and gene expression. The recognition of queuosine as a key player in cellular function may accelerate the exploration of dietary interventions and microbial therapies aimed at enhancing healthspan and mitigating age-related diseases. As the scientific community begins to appreciate the importance of this previously overlooked nutrient, future studies may focus on its potential in clinical settings, paving the way for innovative strategies in preventive medicine and therapeutics.

Source: sciencedaily.com